Development of an EORTC module for renal cancer patients: phase I-II - EORTC RCC

Innsbruck Medical University0 个研究点目标入组 0 人开始时间: 待定最近更新: 2021年11月24日

试验速览

暂无简介。

•Inclusion Criteria for the patients:
•1.Patients with a diagnosis of renal cell cancer (irrespective of treatment or follow up status)
•2.Patients who are18 years of age or above
•3.Patients with no other concurrent malignancies
•4.Patients with no cognitive impairment
•5.Patients willing to provide written informed consent for the study
•Inclusion criteria for HCPs:
•1.Consultants from any of the specialist disciplines of medical oncology, surgical oncology, other (radiation oncology) treating patients with RCC
•2.Consultants of either gender
•3.Willing to participate and provide a written informed consent

•Exclusion criteria for patients:
•1.None. Anyone fulfilling the inclusion criteria will be eligible for the study.
•Exclusion criteria for HCPs:
•1.None. Anyone fulfilling the inclusion criteria will be eligible for the study
•2.Patients not willing to provide written informed consent

发起方

Innsbruck Medical University